Every story in this section, newest first — page 155 of 373.
Powerfleet (NASDAQ:AIOT) executed an agreement for a five-year contract in South Africa with an anticipated total value of $100–$120 million as it reported an 11% increase in fourth-quarter revenue to $114.5 million.
Ecopetrol (NYSE:EC) executed a final six-year collective bargaining agreement with the Oil Workers Union (USO) to establish structured labor frameworks through the end of the decade.
Comtech Telecommunications (NASDAQ:CMTL) reported its financial performance for the third quarter ended April 30, 2026, delivering net sales of $106 million.
Ascentage Pharma (NASDAQ:AAPG) presented 17 distinct clinical updates highlighting oncology data for its core therapeutic candidates at the EHA2026 Congress in Copenhagen.
Teledyne FLIR Defense, an operating division of Teledyne Technologies Incorporated (NYSE:TDY), introduced its new Black Recon autonomous micro-drone system at the Eurosatory defense exhibition in Paris.
Magnera (NYSE:MAGN) executed an agreement to sell 100 percent of its shares in the Caerphilly, United Kingdom manufacturing operations to Polyart Group.
VAALCO Energy (NYSE:EGY) executed successful drilling completions across its international asset portfolio, bringing new development wells online in offshore Gabon and onshore Egypt.
Shell (NYSE:SHEL) confirmed the euro and pound sterling equivalents for its first quarter 2026 interim dividend of US$0.3906 per ordinary share, originally announced on May 7, 2026.
Fox (NASDAQ:FOX) signed a definitive merger agreement to buy Roku (NASDAQ:ROKU) for $160 per share to combine traditional broadcasting assets with connected television distribution infrastructure.
Medicus Pharma (NASDAQ:MDCX) announced the submission of a Rare Pediatric Disease Designation request to the FDA for its SkinJect therapy.
Elanco Animal Health Incorporated (NYSE:ELAN) announced on June 15, 2026, that it has received U.S. Department of Agriculture (USDA) approval for its new canine combination vaccine, TruCan Ultra Lyme-L4.
The United States and Iran have reached an agreement to permanently terminate military operations on all fronts and reopen the Strait of Hormuz.
Disc Medicine (NASDAQ:IRON) disclosed positive, updated clinical data across its core hematology pipeline during the 2026 European Hematology Association (EHA) Annual Meeting in Stockholm, Sweden.
Gilead Sciences (NASDAQ:GILD) announced the deployment of an initial emergency donation of more than 2,000 vials of its intravenous antiviral therapy, remdesivir, to the Republic of Uganda.
Triple Flag Precious Metals (NYSE:TFPM) announced that its wholly owned subsidiary, Triple Flag International, has entered into a definitive agreement to acquire a gold stream on the producing Ravenswood Gold Mine in Queensland, Australia.
Cogent Biosciences (NASDAQ:COGT) unveiled highly supportive preclinical findings for its novel small molecule therapeutic candidate, CGT1145, at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden.
UniFirst (NYSE:UNF) shareholders voted decisively to approve the company’s pending acquisition by Cintas (NASDAQ:CTAS) during a special meeting.
Cogent Biosciences (NASDAQ:COGT) announced detailed clinical results from its registration-directed APEX trial evaluating its investigational precision therapy, bezuclastinib, in patients with advanced systemic mastocytosis (AdvSM).
Independent Bank (NASDAQ:IBCP) secured key regulatory approvals required to complete its previously announced acquisition of HCB Financial, the parent company of Highpoint Community Bank.
Jazz Pharmaceuticals (NASDAQ:JAZZ) announced top-line results from the Phase 3 LAGOON clinical trial evaluating Zepzelca (lurbinectedin) in patients with relapsed, second-line metastatic small cell lung cancer (SCLC).
Baidu (NASDAQ:BIDU) announced that AmiGo, an on-demand autonomous mobility service developed through its Apollo Go intelligent driving division in partnership with Swiss Post's PostBus, has secured a special operating permit from Switzerland’s Federal Roads Office (FEDRO) for highly automated (Level 4) operations.
SharonAI Holdings (NASDAQ:SHAZ) announced a major six-year strategic compute collaboration with NVIDIA (NASDAQ:NVDA) to massively scale sovereign artificial intelligence infrastructure across Australia.
MBX Biosciences (NASDAQ:MBX) announced detailed results from its 12-week Avail Phase 2 clinical trial and new one-year data from an ongoing open-label extension study evaluating its investigational endocrine therapy, canvuparatide.
BioCryst Pharmaceuticals (NASDAQ:BCRX) reported new clinical trial data and supportive real-world evidence evaluating its hereditary angioedema (HAE) portfolio at the European Academy of Allergy and Clinical Immunology (EAACI) 2026 Annual Meeting in Istanbul, Turkey.
